Frank D. Lee
Oprichter bij Dragonfly Sciences, Inc.
Profiel
Frank D.
Lee is the founder.
He founded Adnexus in 2002, where he held the title of Chairman & Chief Executive Officer.
He also founded Dragonfly Sciences, Inc. in 2005, where he holds the title of President, Secretary, Treasurer & Director.
Dr. Lee is also the founder of Epitome Biosystems, Inc. .
Dr. Lee's former job(s) include being the Director-Molecular Biology Research at DNAX Research, Inc. and Schering-Plough (India).
Pvt Ltd.
He was also the Chief Technology Officer at Millennium Pharmaceuticals, Inc. from 1994 to 2001.
Dr. Lee's education history includes a doctorate degree from Stanford University in 1982 and an undergraduate degree from the University of California, Berkeley in 1972.
Actieve functies van Frank D. Lee
| Bedrijven | Functie | Begin |
|---|---|---|
Dragonfly Sciences, Inc.
 Dragonfly Sciences, Inc. BiotechnologyHealth Technology Dragonfly Sciences, Inc. develops biosimilar products of monoclonal antibodies and soluble receptors. The company was founded by Frank D. Lee in 2005 and is headquartered in Wellesley, MA. | Oprichter | 01-01-2005 |
Eerdere bekende functies van Frank D. Lee
| Bedrijven | Functie | Einde |
|---|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2001 |
Epitome Biosystems, Inc.
 Epitome Biosystems, Inc. BiotechnologyHealth Technology Epitome Biosystems was founded in 2004 by experts in the field of proteomic analysis. Backed by Flagship Ventures in Cambridge, MA, and with an outstanding Scientific Advisory Board, Epitome is set to become a world leader in multiplex protein analysis | Oprichter | - |
| Schering-Plough (India) Pvt Ltd. | Corporate Officer/Principal | - |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Oprichter | - |
| DNAX Research, Inc. | Corporate Officer/Principal | - |
Opleiding van Frank D. Lee
| University of California, Berkeley | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
| DNAX Research, Inc. | |
Dragonfly Sciences, Inc.
Dragonfly Sciences, Inc. BiotechnologyHealth Technology Dragonfly Sciences, Inc. develops biosimilar products of monoclonal antibodies and soluble receptors. The company was founded by Frank D. Lee in 2005 and is headquartered in Wellesley, MA. | Health Technology |
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Health Technology |
| Schering-Plough (India) Pvt Ltd. | |
Epitome Biosystems, Inc.
Epitome Biosystems, Inc. BiotechnologyHealth Technology Epitome Biosystems was founded in 2004 by experts in the field of proteomic analysis. Backed by Flagship Ventures in Cambridge, MA, and with an outstanding Scientific Advisory Board, Epitome is set to become a world leader in multiplex protein analysis | Health Technology |
